Reirradiation for recurrent gynecologic cancer using high-dose-rate brachytherapy in Japan: A multicenter survey on practice patterns and outcomes
Authors:
- Fumiaki IsohashiFIFumiaki Isohashi
- Ken YoshidaKYKen Yoshida
- Naoya MurakamiNMNaoya Murakami
- Koji MasuiKMKoji Masui
- Shunichi IshiharaSIShunichi Ishihara
- Yu OhkuboYOYu Ohkubo
- Yuko KaneyasuYKYuko Kaneyasu
- Rumiko KinoshitaRKRumiko Kinoshita
- Tadayuki KotsumaTKTadayuki Kotsuma
- Eiichi TanakaETEiichi Tanaka
- Ayaka NagaoANAyaka Nagao
- 5 April 2024
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 195, 110269
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A national surveillance study of the current status of reirradiation using brachytherapy in JapanBrachytherapy, 2021
- American Brachytherapy Society working group report on the patterns of care and a literature review of reirradiation for gynecologic cancersBrachytherapy, 2020
- Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignanciesGynecologic Oncology, 2019
- Re-irradiation in Gynaecological Malignancies: A ReviewClinical Oncology, 2018
- MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancerBrachytherapy, 2017
- Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)The Lancet, 2017
- Concurrent chemoradiotherapy vs . radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysisGynecologic Oncology, 2017
- Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancerGynecologic Oncology, 2012
- Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: Is still the clinical involvement of the pelvis wall a real contraindication? A twenty-year experienceGynecologic Oncology, 2010
- Indications for primary and secondary exenterations in patients with cervical cancerGynecologic Oncology, 2006